Ascendis Pharma A (ASND) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to -$9056.4.
- Ascendis Pharma A's EPS (Weighted Average and Diluted) fell 5372.94% to -$9056.4 in Q4 2025 from the same period last year, while for Dec 2025 it was -$9056.4, marking a year-over-year decrease of 5372.94%. This contributed to the annual value of -$4.25 for FY2025, which is 3910.54% up from last year.
- Latest data reveals that Ascendis Pharma A reported EPS (Weighted Average and Diluted) of -$9056.4 as of Q4 2025, which was down 5372.94% from -$19429.5 recorded in Q3 2025.
- Over the past 5 years, Ascendis Pharma A's EPS (Weighted Average and Diluted) peaked at $56971.7 during Q1 2024, and registered a low of -$59937.3 during Q1 2025.
- In the last 5 years, Ascendis Pharma A's EPS (Weighted Average and Diluted) had a median value of -$2960.7 in 2022 and averaged -$3313.1.
- Per our database at Business Quant, Ascendis Pharma A's EPS (Weighted Average and Diluted) tumbled by 3410563.53% in 2023 and then skyrocketed by 20098.75% in 2024.
- Ascendis Pharma A's EPS (Weighted Average and Diluted) (Quarter) stood at -$14.97 in 2021, then tumbled by 101.86% to -$30.22 in 2022, then tumbled by 34105.64% to -$10336.4 in 2023, then skyrocketed by 43.01% to -$5891.1 in 2024, then crashed by 53.73% to -$9056.4 in 2025.
- Its EPS (Weighted Average and Diluted) was -$9056.4 in Q4 2025, compared to -$19429.5 in Q3 2025 and $18132.4 in Q2 2025.